When modelling financial data for ResMed, are you using figures which have been pre-converted into Australian dollars by analysts (or whoever for that matter)?
Or are you doing the exercise with data straight from the annual reports and thus using US dollars?
An additional question, which is no doubt answered by the response to the former is: when computing your ratio's which involve price - are you using the US or AUS listing?
Thanks for the in-depth analysis provided within your posts, I find it very educational.
thinking about risk-adjusted returns, page-4
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
